De-escalation in low-risk, HER2-positive breast cancer. Geuna E, Curigliano G, Montemurro F. Lancet Oncol 2023;24:200-201.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Geuna E, Curigliano G, Montemurro F. De-escalation in low-risk, HER2-positive breast cancer. Lancet Oncol 2023;24:200-201.
PMID: 36858719